Impaired anti-inflammatory function of apolipoprotein A-II concentrations predicts metabolic syndrome and diabetes at 4 years follow-up in elderly Turks


Creative Commons License

ONAT A., Hergenc G., AYHAN E., UGUR M., Can G.

CLINICAL CHEMISTRY AND LABORATORY MEDICINE, vol.47, no.11, pp.1389-1394, 2009 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 47 Issue: 11
  • Publication Date: 2009
  • Doi Number: 10.1515/cclm.2009.310
  • Journal Name: CLINICAL CHEMISTRY AND LABORATORY MEDICINE
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.1389-1394
  • Keywords: apolipoprotein A-II, coronary heart disease, diabetes, metabolic syndrome, proinflammatory state, CORONARY-ARTERY-DISEASE, INSULIN-RESISTANCE, SERUM ADIPONECTIN, TRANSGENIC MICE, RISK, CHOLESTEROL, LIPOPROTEIN, PLASMA, HDL, ASSOCIATION
  • Istanbul University-Cerrahpasa Affiliated: Yes

Abstract

Background: We evaluated prospectively the predictive value of serum apolipoprotein (apo) A-II, the second major apolipoprotein of high-density lipoprotein (HDL), for cardiometabolic risk in Turkish adults showing abnormalities in other proteins that normally confer protection.